Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Stewart

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|May 24, 2017
Combinatorial drug delivery approaches for immunomodulationJoshua M Stewart, Benjamin G Keselowsky
Behavioral Sciences & the Law|February 21, 2018
The prevalence of false confessions in experimental laboratory simulations: A meta-analysisJoshua M Stewart, William Douglas Woody, Steven Pulos
Advanced Healthcare Materials|June 11, 2020
Nano and Microparticle Emerging Strategies for Treatment of Autoimmune Diseases: Multiple Sclerosis and Type 1 DiabetesAlexander J Kwiatkowski, Joshua M Stewart, Jonathan J Cho, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2022
Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in miceAlexander J Kwiatkowski, Eric Y Helm, Joshua M Stewart, et al.
Frontiers in Immunology|November 16, 2020
Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype <i>In Vitro</i> and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell ResponsesMaigan A Brusko, Joshua M Stewart, Amanda L Posgai, et al.
Biomaterials|August 4, 2017
An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitisJonathan J Cho, Joshua M Stewart, Theodore T Drashansky, et al.
ACS Biomaterials Science & Engineering|May 24, 2019
Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse ModelJamal S Lewis, Joshua M Stewart, Gregory P Marshall, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|May 24, 2017
Combinatorial drug delivery approaches for immunomodulationJoshua M Stewart, Benjamin G Keselowsky
Behavioral Sciences & the Law|February 21, 2018
The prevalence of false confessions in experimental laboratory simulations: A meta-analysisJoshua M Stewart, William Douglas Woody, Steven Pulos
Advanced Healthcare Materials|June 11, 2020
Nano and Microparticle Emerging Strategies for Treatment of Autoimmune Diseases: Multiple Sclerosis and Type 1 DiabetesAlexander J Kwiatkowski, Joshua M Stewart, Jonathan J Cho, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2022
Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in miceAlexander J Kwiatkowski, Eric Y Helm, Joshua M Stewart, et al.
Frontiers in Immunology|November 16, 2020
Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype <i>In Vitro</i> and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell ResponsesMaigan A Brusko, Joshua M Stewart, Amanda L Posgai, et al.
Biomaterials|August 4, 2017
An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitisJonathan J Cho, Joshua M Stewart, Theodore T Drashansky, et al.
ACS Biomaterials Science & Engineering|May 24, 2019
Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse ModelJamal S Lewis, Joshua M Stewart, Gregory P Marshall, et al.
Pageof 1